Medical University Innsbruck: COVID-19 trials

The registry lists 13 COVID-19 studies with Medical University Innsbruck as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 1Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Building Resilience During the COVID-19 Pandemic: a Randomized Controlled TrialRecruitingNCT05802875Not applicable
• Stopping ACE-inhibitors in COVID-19CompletedNCT04353596Phase 4Results posted
• Olfactory Training in COVID-19 Associated Loss of SmellCompletedNCT05421221Not applicable
• α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19CompletedNCT05401773
• COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CFCompletedNCT05054582
• Neurological Outcome After SARS-CoV-2 InfectionStatus unknownNCT05025839
• Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2Status unknownNCT04907331Phase 2
• Health After Covid-19 in TyrolStatus unknownNCT04661462
• COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive MeasuresCompletedNCT04649333
• Perception of the COVID-19 Pandemic in Patients With Haematological or Solid NeoplasiasStatus unknownNCT04649320
• VRQOL in Cataract Patients During the COVID-19 PandemicStatus unknownNCT04468308
• Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19CompletedNCT04444596Not applicable
• Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)Status unknownNCT04416100